|
Number of predicted targets for 5 datasets |
|||||
| miRNA Data Set |
Number of co-expressed miRNAs |
Total Number of Targets |
Total number of targets from enrichment analysis (GO BP), p < 0.05 |
Number of targets from GO BP categories targeted by >50% of miRNAs |
Number of targets from GO BP categories targeted by 100% of miRNAs |
|
|
|||||
| Lymphoma (cistron miR-17-92 only) |
7 |
2175 |
962 |
918 |
851 |
| Breast Cancer |
14 |
3462 |
805 |
720 |
546 |
| Colon Cancer |
20 |
3439 |
828 |
711 |
578 |
| Lung Cancer |
33 |
4942 |
700 |
560 |
192 |
| Pancreatic Cancer |
47 |
5356 |
996 |
841 |
702 |
Gusev et al. BMC Bioinformatics 2007 8(Suppl 7):S16 doi:10.1186/1471-2105-8-S7-S16 |
|||||